Literature DB >> 26022761

US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions.

Leigh G Turner.   

Abstract

Keywords:  US FDA; adipose-derived mesenchymal stromal cells; marketing claims; patient safety

Mesh：

Year:  2015        PMID： 26022761     DOI： 10.2217/rme.15.10

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  4 in total

1.  Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

Authors:  Ajay E Kuriyan; Thomas A Albini; Justin H Townsend; Marianeli Rodriguez; Hemang K Pandya; Robert E Leonard; M Brandon Parrott; Philip J Rosenfeld; Harry W Flynn; Jeffrey L Goldberg
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

2.  The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar.

Authors:  Paul S Knoepfler
Journal:  Stem Cells Transl Med       Date:  2016-08-02       Impact factor: 6.940

3.  Rogue stem cell clinics.

Authors:  Iain R Murray; Jorge Chahla; Rachel M Frank; Nicolas S Piuzzi; Bert R Mandelbaum; Jason L Dragoo
Journal:  Bone Joint J       Date:  2020-02       Impact factor: 5.082

4.  The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.

Authors:  Ubaka Ogbogu; Jenny Du; Yonida Koukio
Journal:  BMC Med Ethics       Date:  2018-05-02       Impact factor: 2.652
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.